MimiI-NanHuMD
Endocrinology • Houston, TXDiabetes, Osteoporosis & Bone Metabolism Medicine, Parathyroid, Thyroid
Professor Endocrine Neoplasia and Hormonal Disorders The University of Texas MD Anderson Cancer Center
Dr. Hu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd, Unit 1461
Houston, TX 77030Phone+1 713-792-2841
Education & Training
Baylor College of MedicineFellowship, Endocrinology, Diabetes, and Metabolism, 2004 - 2007- Baylor College of MedicineResidency, Internal Medicine, 2000 - 2004
McGovern Medical School at UTHealthClass of 2000
Certifications & Licensure
FL State Medical License 2021 - Present
GA State Medical License 2023 - 2027
AZ State Medical License 2023 - 2026
LA State Medical License 2023 - 2026
TN State Medical License 2023 - 2026
TX State Medical License 2002 - 2026
WA State Medical License 2023 - 2026
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism- Join now to see all
Awards, Honors, & Recognition
- Top Doctors:SE Texas Castle Connolly, 2013
- Super Doctor SuperDoctors.com
Publications & Presentations
PubMed
- Approach to the Patient: Hereditary Medullary Thyroid Carcinoma.Omair A Shariq, Steven G Waguespack, Sarah Hamidi, Benjamin C Kensing, Mimi I Hu
The Journal of Clinical Endocrinology and Metabolism. 2025-03-19 - 2 citationsClinical Activity of Selpercatinib in RET-mutant Pheochromocytoma.Barbara Deschler-Baier, Bhavana Konda, Erminia Massarelli, Mimi I Hu, Lori J Wirth
The Journal of Clinical Endocrinology and Metabolism. 2025-02-18 - Systemic Therapies for Advanced Medullary Thyroid Carcinoma.Marco Ruiz Santillan, Ramona Dadu, Robert F Gagel, Elizabeth G Grubbs, Mimi I Hu
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer. 2025-01-01
Press Mentions
Preview of the 93rd American Thyroid Association Annual MeetingJuly 1st, 2024- Targeted Therapy Pralsetinib Safely Effectively Treats Lung and Thyroid Cancers with RET AlterationsJune 9th, 2021
- Gavreto Gets Accelerated Approval for RET-Altered Thyroid CancersDecember 3rd, 2020
- Join now to see all
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
